Articles
Packaging Trends and the Future of the Generics Market in India
Around the world, the pharmaceutical market is rapidly evolving, driven by greater access to medicines, an increased focus on patient needs and the emergence of innovative therapies for chronic conditions such as diabetes, multiple sclerosis and rheumatoid arthritis.
Industry analyst...
Articles
Environmental concerns in China leading to closure of factories that make the basic raw materials and key starting materials required for the API industry...
Environmental concerns in China leading to closure of factories that make the basic raw materials and key starting materials required for the API industry to be dearer?
There has been a consistent increase in KSM (Key starting material) prices for...
Articles
Getting the Supply Chain Right for Biologics
The relationship between pharmaceutical and biopharmaceutical companies and drug delivery system manufacturers has evolved over the past 20 years. In the past, the relationships were purely transactional, but this has changed over the last two decades.
An increase in sensitive...
Articles
RABS and isolator cleanroom technology combined in V-CRT®
Significant innovation in disease treatment, including the increased focus on complex biologic therapies1, has resulted in important industry trends that have had an impact on many aspects of aseptic processing.
For example:
Pharmaceutical portfolios are shifting as companies meet the...
Articles
Moving Serialization Forward: Using Automated Processes To Connect Pharmaceutical Manufacturing With The Supply Chain
While the requirements for serialization in the pharmaceutical supply chain are generally regarded as inevitable counterfeiting is simply too large of a problem to not be addressed there is some uncertainty around the specifics,particularly globally.
Regulations are advancing at various...
Articles
Solving the Patient Recruitment Dilemma
Patient recruitment is often cited as one of the biggest challenges faced by clinical trial professionals. Many clinical trials fail because sponsors cannot recruit sufficient patients to reach their target sample size.
In fact, only 55% of trials reach enrolment...
Articles
Rebooting the life science industry with digital technology
Digital technology has been driving change throughout the life science industry for years, however the sector is currently standing on the precipice of revolutionary development – some organizations have already taken the jump towards a more digital future.
Data collection...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read